160 related articles for article (PubMed ID: 17559372)
1. Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer.
Zhao X; Huang K; Zhu Z; Chen S; Hu R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1317-21. PubMed ID: 17559372
[TBL] [Abstract][Full Text] [Related]
2. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
[TBL] [Abstract][Full Text] [Related]
3. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.
Yao JC; Wang L; Wei D; Gong W; Hassan M; Wu TT; Mansfield P; Ajani J; Xie K
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4109-17. PubMed ID: 15217947
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
5. [Expression of HER-2 and leptin in gastric cancer and their clinical significance].
Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909
[TBL] [Abstract][Full Text] [Related]
6. Lymph node metastasis as a single predictor in patients with Borrmann type I gastric cancer.
Chen JH; Wu CW; Lo SS; Li AF; Hsieh MC; Shen KH; Lui WY
Hepatogastroenterology; 2007; 54(75):981-4. PubMed ID: 17591108
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
[TBL] [Abstract][Full Text] [Related]
8. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.
Li C; Oh SJ; Kim S; Hyung WJ; Yan M; Zhu ZG; Noh SH
Oncology; 2009; 77(3-4):197-204. PubMed ID: 19729977
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer.
Tsutsumi S; Kuwano H; Shimura T; Morinaga N; Mochiki E; Asao T
Hepatogastroenterology; 2005; 52(62):629-32. PubMed ID: 15816493
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma.
Raica M; Mogoantă L; Cîmpean AM; Alexa A; Ioanovici S; Mărgăritescu C; Lazăr D; Izvernariu D
Rom J Morphol Embryol; 2008; 49(1):37-42. PubMed ID: 18273500
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.
Kamei S; Kono K; Amemiya H; Takahashi A; Sugai H; Ichihara F; Fujii H; Matsumoto Y
J Gastroenterol; 2003; 38(6):540-7. PubMed ID: 12825129
[TBL] [Abstract][Full Text] [Related]
13. The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer.
Ozdemir F; Akdogan R; Aydin F; Reis A; Kavgaci H; Gul S; Akdogan E
J Exp Clin Cancer Res; 2006 Mar; 25(1):83-8. PubMed ID: 16761623
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
16. Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancer.
Gong W; Jiang Y; Wang L; Wei D; Yao J; Huang S; Fang S; Xie K
Clin Cancer Res; 2005 Aug; 11(16):5778-83. PubMed ID: 16115916
[TBL] [Abstract][Full Text] [Related]
17. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
[TBL] [Abstract][Full Text] [Related]
18. Leptin and HER-2 are associated with gastric cancer progression and prognosis of patients.
Geng Y; Wang J; Wang R; Wang K; Xu Y; Song G; Wu C; Yin Y
Biomed Pharmacother; 2012 Sep; 66(6):419-24. PubMed ID: 22883999
[TBL] [Abstract][Full Text] [Related]
19. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
20. Lymphangiogenesis in gastric carcinoma correlates with prognosis.
Gao P; Zhou GY; Zhang QH; Su ZX; Zhang TG; Xiang L; Wang Y; Zhang SL; Mu K
J Pathol; 2009 Jun; 218(2):192-200. PubMed ID: 19224540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
